Drug Type Small molecule drug |
Synonyms KRP 105, KRP105 |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22ClN3O3S |
InChIKeyUEIFAMIUBPSKHA-SFHVURJKSA-N |
CAS Registry876145-69-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Phase 1 | - | - | |
Hyperlipidemias | Phase 1 | Japan | - |